About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT04070521

EEG Monitoring in the Emergency Department

This study seeks to investigate whether drug effects in suspected overdose patients could be identified using the electroencephalogram (EEG). From previous work it is known that different classes of a...

Lead sponsor: Massachusetts General Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Massachusetts General Hospital

Collaborators

Brigham and Women's Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult patients aged 18 years and older who present to the ED with suspected use of a potential drug of abuse

Exclusion Criteria

•Hemodynamic instability or other acute medical condition for which the primary treating team does not thing it would be appropriate or safe for the study staff to approach the patient
•The patient has an overt head trauma or deformity of the face which would preclude application of the forehead EEG monitoring lead
•The patient has dermatological issues or skin conditions on the forehead
•The patient has known dementia and/or mental impairment
•The patient is a prisoner
•The patient is an employee or student at one of the study sites.

Related studies

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

CEDRN: Opioid Registry

NCT07466784 · Opioid Use Disorder, Opioid Abuse or Dependence, and more

Testing ALERT With GTO in Middle Schools

NCT05219422 · Substance Abuse

LIFUS For Neurological Disorders

NCT07417280 · Parkinson's Disease (PD), Essential Tremor, and more

RECRUITINGPhase 2

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 1, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment10

Start dateSep 2019

Last updatedAug 1, 2023

Condition

Drug Overdose Substance Abuse Alcohol Abuse

Locations shown

Massachusetts General Hospital

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 1, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions